A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric hodgkin lymphoma patients before and after stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A targeted salvage therapy with brentuximab vedotin in heavily treated refractory or relapsed pediatric hodgkin lymphoma patients before and after stem cell transplantation

Published:2019 Issue:5 Volume:61 Page:671
ISSN:0041-4301
Container-title:The Turkish Journal of Pediatrics
language:
Short-container-title:TurkJPediatr

Author:

Taçyıldız Nurdan,Tanyıldız Hikmet Gülşah,Ünal Emel,Dinçaslan Handan,Asarcıklı Fikret,Aksoy Başak Adaklı,Vatansever Göksel,Yavuz Gülsan

Publisher

The Turkish Journal of Pediatrics

Subject

Pediatrics, Perinatology, and Child Health

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model;Indian Journal of Cancer;2024-01-09

2. Efficacy of Brentuximab Vedotin and Nivolumab in Refractory or Relapsed Hodgkin Lymphoma: A Systematic Review;Cureus;2022-03-24

3. Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India;Frontiers in Oncology;2022-02-11

4. Brentuximab-vedotin;Reactions Weekly;2020-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP